KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) Gross Margin (2016 - 2025)

Quest Diagnostics' Gross Margin history spans 17 years, with the latest figure at 32.43% for Q4 2025.

  • For Q4 2025, Gross Margin fell 31.0% year-over-year to 32.43%; the TTM value through Dec 2025 reached 33.21%, up 35.0%, while the annual FY2025 figure was 33.21%, 35.0% up from the prior year.
  • Gross Margin for Q4 2025 was 32.43% at Quest Diagnostics, down from 33.7% in the prior quarter.
  • Across five years, Gross Margin topped out at 40.22% in Q1 2021 and bottomed at 32.17% in Q4 2023.
  • The 5-year median for Gross Margin is 33.62% (2024), against an average of 34.55%.
  • The largest annual shift saw Gross Margin skyrocketed 992bps in 2021 before it plummeted -490bps in 2022.
  • A 5-year view of Gross Margin shows it stood at 37.39% in 2021, then fell by -13bps to 32.49% in 2022, then decreased by -1bps to 32.17% in 2023, then rose by 2bps to 32.74% in 2024, then fell by -1bps to 32.43% in 2025.
  • Per Business Quant, the three most recent readings for DGX's Gross Margin are 32.43% (Q4 2025), 33.7% (Q3 2025), and 34.15% (Q2 2025).